AU535170B2 – Spiro-oxazolidindiones
– Google Patents
AU535170B2 – Spiro-oxazolidindiones
– Google Patents
Spiro-oxazolidindiones
Info
Publication number
AU535170B2
AU535170B2
AU50092/79A
AU5009279A
AU535170B2
AU 535170 B2
AU535170 B2
AU 535170B2
AU 50092/79 A
AU50092/79 A
AU 50092/79A
AU 5009279 A
AU5009279 A
AU 5009279A
AU 535170 B2
AU535170 B2
AU 535170B2
Authority
AU
Australia
Prior art keywords
oxazolidindiones
spiro
Prior art date
1978-08-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50092/79A
Other versions
AU5009279A
(en
Inventor
Rodney Caughren Schnur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1978-08-21
Filing date
1979-08-20
Publication date
1984-03-08
1979-08-20
Application filed by Pfizer Inc
filed
Critical
Pfizer Inc
1980-02-28
Publication of AU5009279A
publication
Critical
patent/AU5009279A/en
1984-03-08
Application granted
granted
Critical
1984-03-08
Publication of AU535170B2
publication
Critical
patent/AU535170B2/en
1999-08-20
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/22—Anxiolytics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A61P27/12—Ophthalmic agents for cataracts
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P3/00—Drugs for disorders of the metabolism
A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P3/00—Drugs for disorders of the metabolism
A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
C07F7/02—Silicon compounds
C07F7/08—Compounds having one or more C—Si linkages
C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
C07F7/1804—Compounds having Si-O-C linkages
AU50092/79A
1978-08-21
1979-08-20
Spiro-oxazolidindiones
Ceased
AU535170B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US935199
1978-08-21
US05/935,199
US4200642A
(en)
1978-08-21
1978-08-21
Spiro-oxazolidindiones
Publications (2)
Publication Number
Publication Date
AU5009279A
AU5009279A
(en)
1980-02-28
AU535170B2
true
AU535170B2
(en)
1984-03-08
Family
ID=25466700
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU50092/79A
Ceased
AU535170B2
(en)
1978-08-21
1979-08-20
Spiro-oxazolidindiones
Country Status (34)
Country
Link
US
(1)
US4200642A
(en)
JP
(4)
JPS6011914B2
(en)
AR
(1)
AR225614A1
(en)
AT
(1)
AT366689B
(en)
AU
(1)
AU535170B2
(en)
BE
(1)
BE878311A
(en)
CA
(1)
CA1121361A
(en)
CH
(1)
CH639974A5
(en)
CS
(1)
CS208129B2
(en)
DD
(1)
DD146602A5
(en)
DE
(2)
DE2933441A1
(en)
DK
(1)
DK258479A
(en)
EG
(1)
EG14639A
(en)
ES
(1)
ES483511A1
(en)
FI
(1)
FI65255C
(en)
FR
(3)
FR2442851A1
(en)
GB
(2)
GB2028318B
(en)
GR
(1)
GR71913B
(en)
HU
(1)
HU179746B
(en)
IE
(1)
IE48932B1
(en)
IL
(1)
IL58076A
(en)
IN
(1)
IN152416B
(en)
IT
(1)
IT1123536B
(en)
LU
(1)
LU81613A1
(en)
NL
(1)
NL7906318A
(en)
NO
(1)
NO792699L
(en)
NZ
(1)
NZ191350A
(en)
PH
(1)
PH18091A
(en)
PL
(1)
PL130686B1
(en)
PT
(1)
PT70086A
(en)
SE
(1)
SE447116B
(en)
SU
(1)
SU942597A3
(en)
YU
(1)
YU41488B
(en)
ZA
(1)
ZA794379B
(en)
Families Citing this family (27)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4329459A
(en)
*
1980-05-05
1982-05-11
The Upjohn Company
Tetrahydrobenzopyran derivatives
US4367234A
(en)
*
1980-07-28
1983-01-04
Pfizer Inc.
Hypoglycemic 5-substituted oxazolidine-2,4-diones
SG56656G
(en)
*
1980-07-28
1987-03-27
Pfizer
Hypoglycemic 5-substituted oxazolidine-2, 4-diones
ES8400116A1
(en)
*
1981-10-13
1983-10-16
Pfizer
Oxazolidinedione derivatives.
US4540700A
(en)
*
1982-04-15
1985-09-10
Alcon Laboratories, Inc.
Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4464385A
(en)
*
1982-04-15
1984-08-07
Alcon Laboratories, Inc.
Treatment of diabetic complications with hydantoins
US4438272A
(en)
1982-04-15
1984-03-20
Alcon Laboratories, Inc.
Spiro-(fluoren-9,4′-imidazolidine)-2′,5′-diones
US4436745A
(en)
1982-04-15
1984-03-13
Alcon Laboratories, Inc.
Method of inhibiting aldose reductase activity
ZA832679B
(en)
*
1982-05-07
1983-12-28
Ici Plc
Indoline derivatives
US4430337A
(en)
*
1982-06-23
1984-02-07
Pfizer Inc.
Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A
(en)
*
1982-12-06
1985-12-03
Pfizer Inc.
Spiro-3-hetero-azolones for treatment of diabetic complications
US4464380A
(en)
*
1983-05-25
1984-08-07
Pfizer Inc.
Imidazolidinedione derivatives
US4533667A
(en)
*
1983-05-25
1985-08-06
Pfizer Inc.
Imidazolidinedione derivatives
DK277484A
(en)
*
1983-06-23
1984-12-24
Hoffmann La Roche
thiazolidine
JPS61200991A
(en)
*
1985-03-04
1986-09-05
Sanwa Kagaku Kenkyusho:Kk
Novel spiro-3-heteroazolidine compound, production thereof, preventive and remedy for diabetic complication comprising same as active ingredient
DE3522791C1
(en)
*
1985-06-26
1987-01-02
Ferroplast Gmbh
Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
HU206618B
(en)
*
1986-01-17
1992-12-28
Pfizer
Process for producing hydroxyacetic acid derivatives for treating complications of diabetes and pharmaceutical compositions containing them
US5039672A
(en)
*
1990-04-05
1991-08-13
Pfizer Inc.
Heterocyclic compounds as aldose reductase inhibitors
US5068332A
(en)
*
1990-10-12
1991-11-26
American Home Products Corporation
Alkylidene analogs of 1′-aminospiro[isoquinoline-4(1H),3′-pyrrolidine]-1,2′,3,5′(2H)-tetrones useful as aldose reductase inhibitors
US5102886A
(en)
*
1990-10-12
1992-04-07
American Home Products Corporation
1′-aminospiro[isoquinoline-4(1H),3′-pyrrolidine]-1,2′,3,5′(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1
(en)
*
1993-07-20
1995-09-01
Adir
New benzospiroalcene derivatives, process for their preparation and pharmaceutical compositions containing them.
ES2265952T3
(en)
1999-06-18
2007-03-01
MERCK & CO., INC.
DERIVATIVES OF ARILTIAZOLIDINDIONA AND ARILOXAZOLIDINDIONA.
WO2000078313A1
(en)
1999-06-18
2000-12-28
Merck & Co., Inc.
Arylthiazolidinedione and aryloxazolidinedione derivatives
ITPI20060083A1
(en)
*
2006-07-11
2008-01-12
Univ Pisa
2,2-DIMETHYLCROMANIC DERIVATIVES 4-SPIRO-HETEROCYCLIC NITROGEN (5 AND 6-TERM)
USD775790S1
(en)
*
2015-11-18
2017-01-10
Ginger Damon
Motorcycle jacket
MY196715A
(en)
2017-12-21
2023-05-02
Essity Hygiene & Health Ab
Absorbent article and method for manufacturing an absorbent article
JP2021507767A
(en)
2017-12-21
2021-02-25
エシティ・ハイジーン・アンド・ヘルス・アクチエボラグ
Absorbent Articles and Methods for Producing Absorbent Articles
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE1204232B
(en)
*
1959-07-16
1965-11-04
Ncr Co
Process for the preparation of derivatives of 3-alkyl-3′-methyl-spiro [benzoxazolin-2, 2 ‘- (2’H-1’-benzopyran)]
US3532744A
(en)
*
1967-07-28
1970-10-06
American Home Prod
1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A
(en)
*
1972-07-10
1974-06-28
Ayerst Mckenna & Harrison
Compositions for and a method of treating diabetic complications
CA1088945A
(en)
*
1976-10-18
1980-11-04
Pfizer Limited
Hydantoin derivatives as therapeutic agents
1978
1978-08-21
US
US05/935,199
patent/US4200642A/en
not_active
Expired – Lifetime
1979
1979-06-20
DK
DK258479A
patent/DK258479A/en
not_active
Application Discontinuation
1979-06-21
IN
IN451/DEL/79A
patent/IN152416B/en
unknown
1979-07-27
GB
GB7926348A
patent/GB2028318B/en
not_active
Expired
1979-08-16
YU
YU1999/79A
patent/YU41488B/en
unknown
1979-08-16
CH
CH752879A
patent/CH639974A5/en
not_active
IP Right Cessation
1979-08-17
HU
HU79PI685A
patent/HU179746B/en
unknown
1979-08-17
DE
DE19792933441
patent/DE2933441A1/en
active
Granted
1979-08-17
DE
DE2953954A
patent/DE2953954C2/de
not_active
Expired
1979-08-17
FI
FI792567A
patent/FI65255C/en
not_active
IP Right Cessation
1979-08-17
CA
CA000333955A
patent/CA1121361A/en
not_active
Expired
1979-08-18
JP
JP54105459A
patent/JPS6011914B2/en
not_active
Expired
1979-08-20
ZA
ZA00794379A
patent/ZA794379B/en
unknown
1979-08-20
NZ
NZ191350A
patent/NZ191350A/en
unknown
1979-08-20
GR
GR59870A
patent/GR71913B/el
unknown
1979-08-20
IE
IE1592/79A
patent/IE48932B1/en
not_active
IP Right Cessation
1979-08-20
BE
BE0/196785A
patent/BE878311A/en
not_active
IP Right Cessation
1979-08-20
SU
SU792803649A
patent/SU942597A3/en
active
1979-08-20
SE
SE7906949A
patent/SE447116B/en
not_active
IP Right Cessation
1979-08-20
IL
IL58076A
patent/IL58076A/en
unknown
1979-08-20
FR
FR7920969A
patent/FR2442851A1/en
active
Granted
1979-08-20
LU
LU81613A
patent/LU81613A1/en
unknown
1979-08-20
AT
AT0560579A
patent/AT366689B/en
not_active
IP Right Cessation
1979-08-20
IT
IT25182/79A
patent/IT1123536B/en
active
1979-08-20
AU
AU50092/79A
patent/AU535170B2/en
not_active
Ceased
1979-08-20
PT
PT70086A
patent/PT70086A/en
unknown
1979-08-20
NO
NO792699A
patent/NO792699L/en
unknown
1979-08-20
EG
EG79509A
patent/EG14639A/en
active
1979-08-20
ES
ES483511A
patent/ES483511A1/en
not_active
Expired
1979-08-21
CS
CS795699A
patent/CS208129B2/en
unknown
1979-08-21
PL
PL1979217881A
patent/PL130686B1/en
unknown
1979-08-21
DD
DD79215099A
patent/DD146602A5/en
unknown
1979-08-21
NL
NL7906318A
patent/NL7906318A/en
active
Search and Examination
1979-08-21
PH
PH22931A
patent/PH18091A/en
unknown
1979-08-21
AR
AR277784A
patent/AR225614A1/en
active
1979-08-27
GB
GB8001161A
patent/GB2033904B/en
not_active
Expired
1979-11-16
JP
JP54148748A
patent/JPS6011915B2/en
not_active
Expired
1979-11-16
JP
JP54148749A
patent/JPS5943954B2/en
not_active
Expired
1979-11-16
JP
JP54148747A
patent/JPS5946517B2/en
not_active
Expired
1980
1980-02-07
FR
FR8002698A
patent/FR2440950A1/en
active
Granted
1980-02-07
FR
FR8002697A
patent/FR2440949A1/en
active
Granted
Also Published As
Publication number
Publication date
GB2033904B
(en)
1982-08-04
PT70086A
(en)
1979-09-01
ATA560579A
(en)
1981-09-15
JPS5946517B2
(en)
1984-11-13
JPS6011915B2
(en)
1985-03-28
IL58076A
(en)
1982-07-30
DE2953954A1
(en)
1982-09-02
GB2028318A
(en)
1980-03-05
FI65255B
(en)
1983-12-30
DE2933441A1
(en)
1980-02-28
GR71913B
(en)
1983-08-16
IN152416B
(en)
1984-01-07
DD146602A5
(en)
1981-02-18
JPS55129279A
(en)
1980-10-06
DE2953954C2
(en)
1987-12-03
FR2440950B1
(en)
1981-06-12
LU81613A1
(en)
1980-04-21
IT1123536B
(en)
1986-04-30
PL130686B1
(en)
1984-08-31
DE2933441C2
(en)
1987-04-23
US4200642A
(en)
1980-04-29
CA1121361A
(en)
1982-04-06
SE7906949L
(en)
1980-02-22
EG14639A
(en)
1985-03-31
PH18091A
(en)
1985-03-20
CH639974A5
(en)
1983-12-15
JPS55129288A
(en)
1980-10-06
JPS6011914B2
(en)
1985-03-28
IE791592L
(en)
1980-02-21
GB2028318B
(en)
1982-08-04
PL217881A1
(en)
1981-01-02
YU41488B
(en)
1987-08-31
FI65255C
(en)
1984-04-10
IT7925182D0
(en)
1979-08-20
ES483511A1
(en)
1980-09-01
JPS55129280A
(en)
1980-10-06
FR2440949B1
(en)
1981-06-12
ZA794379B
(en)
1980-08-27
IE48932B1
(en)
1985-06-26
CS208129B2
(en)
1981-08-31
FR2440949A1
(en)
1980-06-06
NO792699L
(en)
1980-02-22
GB2033904A
(en)
1980-05-29
AR225614A1
(en)
1982-04-15
HU179746B
(en)
1982-12-28
AU5009279A
(en)
1980-02-28
SU942597A3
(en)
1982-07-07
FR2442851A1
(en)
1980-06-27
YU199979A
(en)
1983-06-30
BE878311A
(en)
1980-02-20
FR2442851B1
(en)
1983-06-17
NZ191350A
(en)
1984-04-27
NL7906318A
(en)
1980-02-25
DK258479A
(en)
1980-02-22
AT366689B
(en)
1982-04-26
FR2440950A1
(en)
1980-06-06
SE447116B
(en)
1986-10-27
IL58076A0
(en)
1979-12-30
JPS5528996A
(en)
1980-02-29
FI792567A
(en)
1980-02-22
JPS5943954B2
(en)
1984-10-25
Similar Documents
Publication
Publication Date
Title
AU4782679A
(en)
1979-12-13
Oxygenerator
AU4569779A
(en)
1979-10-18
4-aza-17-substituted-5a-androstan-3-ones
AU1328683A
(en)
1983-08-04
O-alkoxycarbonyl benzenesulfonylisocyanates
AU5035479A
(en)
1980-03-06
2-nitroimidazoles
AU4583279A
(en)
1979-10-25
Cycloalkyltriazoles
AU4876779A
(en)
1980-01-17
Oxybenzylidiene-bornanones
AU4529679A
(en)
1979-10-18
N-heterocyclyl-4-piperidinamines
AU4655479A
(en)
1979-11-01
Ear-plugs
AU4825779A
(en)
1980-01-03
Benzofuranyl-piperidines
AU535170B2
(en)
1984-03-08
Spiro-oxazolidindiones
AU4398379A
(en)
1979-08-23
9-amino-dibenzopyrans
AU4666779A
(en)
1979-11-22
Azolopyrimidinones
AU4406379A
(en)
1979-08-16
1-aryloxy-3-hitratoalkylamino-2-propanols
AU4754479A
(en)
1979-12-06
Carbamimido thiaotes
AU4642179A
(en)
1979-11-08
4-quinolinylaminobenzoylpiperidines
AU5064479A
(en)
1980-03-27
3-unsubstituted-3-cephems
AU4530579A
(en)
1979-11-08
Plansifters
AU4571479A
(en)
1979-10-18
2-aminopyrimidones
AU4524379A
(en)
1979-09-27
N-oxacyclic-alkylpiperidyl-diazacompounds
AU4506179A
(en)
1979-09-20
Nitrodiarylamines
AU4946279A
(en)
1980-02-07
Imidazoquinoxalines
AU4830279A
(en)
1980-01-03
Indolealylamines
AU4507279A
(en)
1979-09-20
Phenoxyalkylamines
AU4814679A
(en)
1980-01-03
Rid-mowse
AU4398479A
(en)
1979-08-16
N-azolylalkyl-halogenoacetanilides
None